Cited by 14Phytochemical Studies and BioactivitiesMedicinal Plant ResearchMedicinal Plants and Bioactive Compounds

Effects of Leuzea carthamoides on Human Breast Adenocarcinoma MCF-7 Cells Determined by Gene Expression Profiling and Functional Assays

Gaube, Friedemann, Wölfl, Stefan, Pusch, Larissa, Werner, Ulrike, Kroll, Torsten, Schrenk, Dieter, Hartmann, Rolf, Hamburger, Matthias·2008·Planta Medica

Abstract

Products derived from roots of Leuzea carthamoides (Maral root) are being promoted as dietary supplements with anti-aging, adaptogenic and anabolic activity, without much scientific evidence. We investigated the effects of a lipophilic Leuzea root extract and the major phytoecdysteroid, 20-hydroxyecdysone, in human breast adenocarcinoma MCF-7 cells. Cell proliferation was inhibited by the extract (IC50 = 30 microg/mL) but not by 20-hydroxyecdysone. Genome-wide expression profiling using Affymetrix HG U133 Plus 2.0 microarrays was carried out to analyse effects at the transcriptional level. 241 genes appeared to be differentially expressed after Leuzea treatment, more than after treatment with either 17beta-estradiol or tamoxifen. Transcripts linked to cell cycle regulation and DNA replication were highly over-represented and regulated in an anti-proliferative manner. Genes involved in apoptosis were regulated in a pro-apoptotic manner. Expression levels of several oxidoreductase transcripts were strongly induced, most prominent CYP1A1, known to be regulated via the aryl hydrocarbon receptor pathway. An XRE-dependent reporter gene assay confirmed the AhR-agonistic activity of the Leuzea root extract, whereas 20-hydroxyecdysone was not active. Leuzea extract also inhibited 5alpha-reductase, type II. While the extract significantly modulates cellular activities, the phytoecdysteroids, are most likely not the active principles of L. carthamoides.

Integrity signals

Registry

Crossref · 10.1055/s-0028-1088316

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Extracts from Rhaponticum carthamoides show antibacterial, cytotoxic, anti-adipogenic, and antioxidant activities.

    “Extracts from R. carthamoides show a variety of activities, including antibacterial, cytotoxic, anti-adipogenic, and antioxidant [69,121,122,123,124,125,126,127,128,129,130,131,132].”
  • Investigations into Rhaponticum carthamoides revealed that its extracts are low in toxicity.

    “The investigations into R. carthamoides revealed that its extracts are low in toxicity [69,121,122,123,124,125,126,127,128,129,130,131,132].”
  • A lipophilic Leuzea root extract containing the major phytoecdysteroid 20-HE demonstrated potent cytotoxic effects on MCF-7 cells with IC50 30 μg/mL, yet 20-HE alone was not as effective.

    “A lipophilic Leuzea root extract containing the major PE 20-HE demonstrated potent cytotoxic effects on MCF-7 cells. The extract exhibitied cell proliferation with IC50 30 μg/mL, yet 20-HE alone was not as effective171.”
  • The anticancer effects of a lipophilic Leuzea root extract containing 20-HE were mediated via gene regulation in an antiproliferative manner through downregulation of CCNE2, FOXM1, GTSE1, and PCNA and induced expression of CCNG2, GADD45α, and TP53INP1, pointing to cell cycle arrest at the G1/S transition checkpoint in MCF-7 cells.

    “The anticancer effects of a lipophilic Leuzea root extract containing 20-HE was found to be medated via gene regulation in an antiproliferative manner through downregulation of cyclin E2 (CCNE2), forkhead box M1 (FOXM1), G-2 and S-phase expressed 1 (GTSE1), proliferating cell nuclear antigen (PCNA), induced expression of cyclin G2 (CCNG2), growth arrest and DNA-damage-inducible, alpha (GADD45α)”
  • Approximately thirty genes associated with DNA replication and synthesis appeared downregulated by Leuzea extract, indicating that reduced replication rate and cell cycle arrest at the G1/S transition checkpoint is more specific than the molecule mechanism in MCF-7 cells.

    “In addition, approximately thirty genes associated with DNA replication and synthesis appeared to be downregulated by the extract, which indicated that reduced replication rate and cell cycle arrest at the G1/S-transition checkpoint is more specific than the molecule mechanism in MCF-7 cells171.”

The citation lists haven’t been fetched yet

References 19 · Cited by 14

Authors
Gaube, F., Wölfl, S., Pusch, L., Werner, U., Kroll, T., Schrenk, D., Hartmann, R., & Hamburger, M.
Affiliations
  • Friedrich Schiller University Jena (DE)
  • Heidelberg University (DE)
  • University of Kaiserslautern (DE)
  • Saarland University (DE)
  • University of Basel (CH)
Venue
Planta Medica
Published
2008-10-29
Volume
74
Issue
14
Pages
1701-1708
ISSN
  • 0032-0943 (ISSN-L)
  • 1439-0221
OpenAlex
W1997876148
Cited by
14
References
19
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 2 · 2013: 1
FWCI
0.41
Type
journal article
Language
en
Open access
closed
Locations
  • Planta Medica (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phytochemical Studies and Bioactivities
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Medicinal Plants and Bioactive Compounds
Keywords
Leuzea carthamoides, 20-hydroxyecdysone, phytoecdysteroids, breast adenocarcinoma, MCF-7 cells, cell proliferation inhibition, apoptosis, cell cycle regulation, DNA replication, CYP1A1, aryl hydrocarbon receptor, gene expression profiling, dietary supplements, anti-aging products
MeSH terms
Adenocarcinoma, Breast Neoplasms, Female, Humans, Plant Extracts, Gene Expression Regulation, Neoplastic, Genome, Plant Roots, Gene Expression Profiling, Leuzea, Cell Line, Tumor, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review